Female sex was associated with lower overall mortality compared to men (18.4% vs 22.0%), driven by better prognosis in HFrEF, though sex was not an independent predictor of death across all subtypes.
Cohort (n=11,282)
No
Does female sex compared to male sex affect mortality in patients with heart failure across different ejection fraction categories?
Women with HFrEF have a better prognosis than men, but mortality is similar in HFmrEF and HFpEF, and sex itself is not an independent predictor of death across all HF subtypes.
Absolute Event Rate: 18.4% vs 22%
BACKGROUND: Heart failure (HF) is one of the leading causes of death worldwide. Studies show that women have better survival rates than men despite higher hospitalizations. However, little is known about differences in mortality and predictors of death in women and men with HF with preserved (HFpEF), mildly reduced (HFmrEF), and reduced ejection fraction (HFrEF). METHODS: From February 2017 to September 2020, mortality and predictors of death were analyzed in women and men with HF. Baseline data included clinical characteristics and echocardiographic findings. RESULTS: A total of 11,282 patients, 63.9 ± 14.4 years, including 6256 (55.4%) males, were studied. Females were older, had a higher baseline mean left ventricular ejection fraction (LVEF) and lower left ventricular diastolic diameter. During follow-ups, 1375 (22%) men and 925 (18.4%) women died. Cumulative incidence of death was higher in men with HFrEF but similar for HFmrEF and HFpEF. Cox regression for death showed renal dysfunction, stroke, diabetes, atrial fibrillation, age, LVEF, valve disease, MI, and hypertensive CMP as independent death predictors for all HF patients. CONCLUSIONS: Women had a better prognosis than men in HFrEF and similar mortality for HFmrEF and HFpEF, but sex was not an independent predictor of death for all HF subtypes.
Mansur et al. (Fri,) conducted a cohort in Heart failure (n=11,282). Female sex vs. Male sex was evaluated on Mortality. Female sex was associated with lower overall mortality compared to men (18.4% vs 22.0%), driven by better prognosis in HFrEF, though sex was not an independent predictor of death across all subtypes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: